Publications by authors named "Bradley J Monk"

100Publications

Asbestos and ovarian cancer: examining the historical evidence.

Int J Gynecol Cancer 2020 Oct 9. Epub 2020 Oct 9.

Gynecologic Oncology, Obstetrics and Gynecology, Arizona Oncology (US Oncology Network), Phoenix, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2020-001672DOI Listing
October 2020

Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance.

Gynecol Oncol 2020 Sep 26. Epub 2020 Sep 26.

Stanford University School of Medicine, Stanford, CA, United States; University of California, Los Angeles, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2020.09.017DOI Listing
September 2020

Management of nausea and vomiting from poly(ADP-ribose) polymerase inhibitor therapy for advanced ovarian cancer.

Gynecol Oncol 2020 Nov 21;159(2):581-587. Epub 2020 Sep 21.

Creighton University School of Medicine, Phoenix, AZ, United States of America; University of Arizona College of Medicine, Phoenix, AZ, United States of America; Arizona Oncology (US Oncology Network), Phoenix, AZ, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2020.08.016DOI Listing
November 2020

Real world experience of poly (ADP-ribose) polymerase inhibitor use in a community oncology practice.

Gynecol Oncol 2020 Oct 15;159(1):112-117. Epub 2020 Aug 15.

Creighton University School of Medicine Phoenix, AZ, United States; University of Arizona College of Medicine Phoenix, AZ, United States; Arizona Oncology (US Oncology Network), Phoenix, AZ, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2020.07.020DOI Listing
October 2020

Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study.

Gynecol Oncol 2020 Oct 26;159(1):79-87. Epub 2020 Jul 26.

Arizona Oncology (US Oncology Network), University of Arizona College of Medicine-Phoenix, Creighton University School of Medicine, St. Joseph's Hospital, Phoenix, AZ, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2020.07.015DOI Listing
October 2020

CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.

Int J Gynecol Cancer 2020 Jul 23;30(7):1065-1070. Epub 2020 May 23.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St. Josephs Hospital and Medical Center, Phoenix, Arizona, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2019-001135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398223PMC
July 2020

Philip John DiSaia, MD: Available Light & The Origin of Storms.

J Obstet Gynaecol Res 2020 Jul 30;46(7):959-988. Epub 2020 Apr 30.

Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jog.14277DOI Listing
July 2020

PARP Inhibitors in Ovarian Cancer. Reply.

N Engl J Med 2020 04;382(16):1574

University of Arizona College of Medicine, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc2000644DOI Listing
April 2020

Letter to the editor, Reply to: Lee and Matulonis: Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?

Gynecol Oncol Rep 2019 Nov 10;30:100506. Epub 2019 Oct 10.

AstraZeneca, 950 Wind River Ln, Gaithersburg, MD 20878, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2019.100506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906726PMC
November 2019

Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy.

Gynecol Oncol 2020 01 4;156(1):100-106. Epub 2019 Dec 4.

Section of Gynecologic Oncology, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.10.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526859PMC
January 2020

Moving beyond cytotoxic drug dosing in ovarian cancer.

Lancet 2019 12 29;394(10214):2043-2045. Epub 2019 Nov 29.

Division of Gynecologic Oncology and Center for Personalized Cancer Therapy, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Diego, Moores Comprehensive Cancer Center, La Jolla, CA 92093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)32948-4DOI Listing
December 2019

Reply to Farolfi et al and Haines et al.

J Clin Oncol 2020 01 7;38(2):173-174. Epub 2019 Nov 7.

Krishnansu S. Tewari, MD, University of California Irvine, Orange, CA; Bradley J. Monk, MD, Creighton University School of Medicine, Omaha, NE; and Robert A. Burger, MD, University of Pennsylvania Perelman School of Medicine,Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.02334DOI Listing
January 2020

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

N Engl J Med 2019 12 28;381(25):2391-2402. Epub 2019 Sep 28.

From Grupo Español de Investigación en Cáncer de Ovario (GEICO) and the Medical Oncology Department, Clínica Universidad de Navarra (A.G.-M.) and GEICO and Hospital Universitario La Paz-IdiPAZ (A.R.), Madrid, GEICO and Medical Oncology, Catalan Institute of Oncology, Girona Biomedical Research Institute, and the Department of Medical Sciences, Medical School University of Girona, Girona (P.B.-G.), and GEICO and Hospital Universitario Reina Sofía, Cordoba (M.J.R.-P.) - all in Spain; the Gynecologic Oncology Group (GOG) and the Department of Obstetrics/Gynecology, Perlmutter Cancer Center, NYU Langone Health (B.P.), and GOG and the Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College (R.E.O.), New York, and US Oncology Research (USOR) and the Division of Gynecologic Oncology, Wilmot Cancer Institute, Department of Obstetrics and Gynecology, University of Rochester, Rochester (R.G.M.) - all in New York; Belgium and Luxembourg Gynecologic Oncology Group (BGOG) and the Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven (I.V.), BGOG and the Department of Medical Oncology and Hematology, AZ Maria Middelares, Ghent (C.V.), and the Department of Molecular Imaging, Pathology, Radiotherapy, and Oncology, Center for Oncological Research, Antwerp University, Antwerp (C.V.) - all in Belgium; the Nordic Society of Gynecologic Oncology (NSGO) and the Research Unit of General Practice, Institute of Public Health, University of Southern Denmark, Odense (R.D.C.), NSGO and Rigshospitalet-Copenhagen University Hospital, Copenhagen (M.R.M.), and NSGO and the Department of Oncology, Aalborg University, Aalborg (B.L.) - all in Denmark; GOG and Gynecologic Oncology, Medical University of South Carolina, Charleston (W.G.); GOG and Legacy Medical Group Gynecologic Oncology, Portland, OR (C.M.); Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) and Fondazione IRCCS National Cancer Institute of Milan (D.L.), and MITO and the Department of Obstetrics and Gynecology, San Raffaele Scientific Institute (G.M.) - both in Milan; USOR and the Department of Medical Oncology, BC Cancer, Vancouver, BC (P.H.), and GOG and the Department of Obstetrics and Gynecology, McGill University, and the Department of Oncology, McGill University Health Centre, Division of Gynecologic Oncology, Montreal (K.J.) - all in Canada; Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens and Service d'Oncologie Médicale, Centre Hospitalier Lyon-Sud, Lyon, France (G.F.); Arbeitsgemeinschaft Gynäkologische Onkologie and the Department of Gynecology and Obstetrics, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany (K.B.); the Division of Gynecologic Oncology, Ohio State University, Columbus (F.B.); GOG and the Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia (A.F.H.), and GOG and Hanjani Institute for Gynecologic Oncology, Asplundh Cancer Pavilion, Abington Jefferson Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Willow Grove (M.S.S.) - all in Pennsylvania; GOG and the Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee (W.H.B.); Israeli Society of Gynecologic Oncology and Department of Gynecology and Gynecologic Oncology, Hillel Yaffe Medical Center, Technion Israel Institute of Technology, Haifa, Israel (I.B.); GlaxoSmithKline/Tesaro, Waltham, MA (K.S., I.A.M., Y.L., D.G.); and Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix (B.J.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1910962DOI Listing
December 2019

Evidence-Based Treatment Paradigms for Management of Invasive Cervical Carcinoma.

J Clin Oncol 2019 09 12;37(27):2472-2489. Epub 2019 Aug 12.

University of Arizona, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.02303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098831PMC
September 2019

The American Society of Clinical Oncology 2019 annual meeting: A review and summary of selected abstracts.

Gynecol Oncol 2019 09 12;154(3):454-460. Epub 2019 Jul 12.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.06.019DOI Listing
September 2019

The Evolving Landscape of Chemotherapy in Newly Diagnosed Advanced Epithelial Ovarian Cancer.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:e141-e151. Epub 2019 May 17.

3 Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_239007DOI Listing
January 2019

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

Lancet Oncol 2019 05 1;20(5):636-648. Epub 2019 Apr 1.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St Joseph's Hospital, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30029-4DOI Listing
May 2019

Relationship between social support, quality of life, and Th2 cytokines in a biobehavioral cancer survivorship trial.

Support Care Cancer 2019 Sep 5;27(9):3301-3310. Epub 2019 Jan 5.

Department of Medicine, Division of Hematology/Oncology, University of California Irvine, 204 Sprague Hall, Irvine, CA, 92697, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-018-4617-z
Publisher Site
http://dx.doi.org/10.1007/s00520-018-4617-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612537PMC
September 2019

Response to "surgical management of cervical cancer by laparoscopy or laparotomy".

Gynecol Oncol Rep 2019 Feb 20;27:6-7. Epub 2018 Nov 20.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital Phoenix, AZ, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23525789183010
Publisher Site
http://dx.doi.org/10.1016/j.gore.2018.11.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259039PMC
February 2019

The American Society of Clinical Oncology 2018 annual meeting: A review and summary of selected abstracts.

Gynecol Oncol 2018 11 31;151(2):e1-e6. Epub 2018 Aug 31.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital, Phoenix, AZ, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.08.018DOI Listing
November 2018

Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.

Oncologist 2018 12 23;23(12):1533-1545. Epub 2018 Aug 23.

Department of Obstetrics and Gynecology, University of Cincinnati Cancer Institute and College of Medicine, Cincinnati, Ohio, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292548PMC
December 2018

Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years.

Gynecol Oncol 2018 09 27;150(3):391-397. Epub 2018 Jun 27.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital Phoenix, AZ, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.06.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102091PMC
September 2018

Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design.

Future Oncol 2018 Sep 27;14(21):2103-2113. Epub 2018 Mar 27.

Arizona Oncology (US Oncology Network), University of Arizona & Creighton University, Phoenix, AZ 85016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0070DOI Listing
September 2018

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study.

Br J Cancer 2018 01 28;118(2):162-170. Epub 2017 Nov 28.

Department of Pathology (SL) and Department of Gynecologic Oncology (KT), Irvine Medical Center, University of California, Orange, CA 92868, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.400DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785748PMC
January 2018

Optimal treatment for platinum-sensitive recurrent ovarian cancer.

Authors:
Bradley J Monk

Clin Adv Hematol Oncol 2017 Sep;15(9):674-676

University of Arizona and Creighton University, Phoenix, Arizona.

View Article

Download full-text PDF

Source
September 2017

Bringing new medicines to women with epithelial ovarian cancer: what is the unmet medical need?

Gynecol Oncol Res Pract 2017 7;4:13. Epub 2017 Sep 7.

Arizona Oncology (US Oncology Network), University of Arizona College of Medicine and Creighton University School of Medicine at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40661-017-0050-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590167PMC
September 2017

FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White Paper.

Gynecol Oncol 2017 10 24;147(1):3-10. Epub 2017 Aug 24.

Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.08.012DOI Listing
October 2017

Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11-001.

Gynecol Oncol Res Pract 2017 14;4:10. Epub 2017 Jul 14.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital, 2222 E. Highland Ave, Suite 400, Phoenix, AZ 85016 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40661-017-0047-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512733PMC
July 2017

The American Society of Clinical Oncology 2017 Annual Meeting: A review and summary of selected abstracts.

Gynecol Oncol 2017 09 8;146(3):443-448. Epub 2017 Jul 8.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital, Phoenix, AZ, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258173097
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2017.06.030DOI Listing
September 2017

Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy.

Gynecol Oncol Res Pract 2017 2;4. Epub 2017 Jun 2.

Brown University Oncology Research Group, Providence, RI USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40661-017-0046-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455112PMC
June 2017

Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma.

Gynecol Oncol 2017 07 6;146(1):11-15. Epub 2017 Apr 6.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital, 2222 E. Highland Avenue, Suite 400, Phoenix, AZ 85016, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.03.508DOI Listing
July 2017

Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?

Gynecol Oncol Res Pract 2017 21;4. Epub 2017 Mar 21.

Early Oncology Development and Clinical Research, Pfizer, 219 East 42nd Street, New York, NY 10017-5755 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40661-017-0045-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361700PMC
March 2017

The development and use of vascular targeted therapy in ovarian cancer.

Gynecol Oncol 2017 05 24;145(2):393-406. Epub 2017 Feb 24.

Arizona Oncology (US Oncology Network) University of Arizona College of Medicine, Creighton University School of Medicine at St. Joseph's Hospital, Phoenix, AZ, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.01.031DOI Listing
May 2017

Carcinogenic human papillomavirus infection.

Nat Rev Dis Primers 2016 12 1;2:16086. Epub 2016 Dec 1.

International Agency for Research on Cancer, Infections and Cancer Epidemiology Group, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrdp.2016.86DOI Listing
December 2016

The American Society of Clinical Oncology 2016 annual meeting: A review and summary of selected abstracts.

Gynecol Oncol 2017 Jan 5;144(1):e1-e7. Epub 2016 Nov 5.

Division of Gynecologic Oncology, University of Arizona at St. Joseph's Hospital, Phoenix, AZ, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.10.035DOI Listing
January 2017

Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients.

Curr Pharm Des 2016 ;22(30):4717-4728

Dignity Health St. Joseph's Hospital and Medical Center, 500 W. Thomas Road, Suite 600, Phoenix, AZ 85013.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967614PMC
http://dx.doi.org/10.2174/1381612822666160505114326DOI Listing
November 2017

Trabectedin as a chemotherapy option for patients with BRCA deficiency.

Cancer Treat Rev 2016 Nov 15;50:175-182. Epub 2016 Sep 15.

Department of Oncology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Via La Masa, 19, 20156 Milan, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.09.009DOI Listing
November 2016

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.

N Engl J Med 2016 12 7;375(22):2154-2164. Epub 2016 Oct 7.

From the Nordic Society of Gynecological Oncology and Rigshospitalet-Copenhagen University Hospital, Copenhagen (M.R.M.), Odense University Hospital (J.H.) and European Network for Gynacological Oncological Trial and Research Unit of General Practice, Institute of Public Health, University of Southern Denmark, Odense (R.D.C.) - all in Denmark; University of Arizona and Creighton University-Phoenix, Phoenix (B.J.M.), and Arizona Oncology Associates, Tuscon (B.J.M., J.B.) - all in Arizona; Princess Margaret Consortium, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto (A.M.O.), British Columbia Cancer Agency, Vancouver (A.V.T.), and McGill University-McGill University Health Centre, Montreal (L.G.) - all in Canada; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and the University of Munich, Munich (S.M.), and Kliniken Essen Mitte, Essen (A.B.) - both in Germany; Grupo Español de Investigación en Cáncer de Ovario (GEICO) and Hospital Universitario La Paz (A.R.), and GEICO and M.D. Anderson Cancer Center Madrid (A.G.-M.), Madrid; French Investigator Group for Ovarian and Breast Cancer (GINECO) and Institut du Cancer de Montpellier, Montpellier (M.F.), and GINECO and Centre Antoine Lacassagne, Nice (P.F.) - both in France; National Cancer Research Institute and UCL Cancer Institute, University College London, London (J.A.L.); Multicenter Italian Trials in Ovarian Cancer/Mario Negri Gynecologic Oncology Group, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milan (D.L.); Belgium and Luxembourg Gynecological Oncology Group and University of Leuven, Leuven, Belgium (I.V.); Kaplan Medical Center, Rehovot, Israel (N.E.B.-B.); AGO-Austria and Medical University Innsbruck, Innsbruck, Austria (C.M.); Central and Eastern European Gynecologic Oncology Group and Uniwersytet Medyczny w Poznaniu, Poznan, Poland (R.M.); Stanford Comprehensive Cancer Institute, Stanford (J.S.B.), and Cedars-Sinai Medical Center, West Hollywood (B.J.R.) - both in California; Oslo University Hospital, Radiumhospitalet, Oslo (A.D.); Northside Hospital, Atlanta (B.B.); Universitetssjukhuset, Linköping, Sweden (P.R.); and Veristat, Southborough (J.P.B.), Tesaro, Waltham (S.A.), and Dana-Farber Cancer Institute, Boston (U.A.M.) - all in Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1611310DOI Listing
December 2016

New Strategies for Multimodality Therapy in Treating Locally Advanced Cervix Cancer.

Semin Radiat Oncol 2016 10 26;26(4):344-8. Epub 2016 May 26.

Department of Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2016.05.003DOI Listing
October 2016

Weekly vs. Every-3-Week Paclitaxel for Ovarian Cancer.

N Engl J Med 2016 06;374(26):2603-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1603849DOI Listing
June 2016

Patient Counseling and Management of Symptoms During Olaparib Therapy for Recurrent Ovarian Cancer.

Oncologist 2016 08 2;21(8):954-63. Epub 2016 Jun 2.

Department of Obstetrics and Gynecology, University of Arizona Cancer Center-Phoenix, Creighton University School of Medicine at Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978548PMC
August 2016

Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study.

Gynecol Oncol Res Pract 2016 14;3. Epub 2016 Apr 14.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center, 500 West Thomas Road, Suite 660, Phoenix, AZ 85013 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40661-016-0025-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880945PMC
May 2016

Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

J Clin Oncol 2016 07 23;34(19):2279-86. Epub 2016 May 23.

Bradley J. Monk, University of Arizona Cancer Center at Dignity Health St Joseph's Hospital and Medical Center, Phoenix, AZ; Michael W. Sill, Roswell Park Cancer Institute, Buffalo; Carol Aghajanian, Memorial Sloan Kettering Cancer Center, New York, NY; Joan L. Walker, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Christopher J. Darus, Maine Medical Center, Portland, ME; Gregory Sutton, Washington University School of Medicine, St. Louis, MO; Krishnansu S. Tewari, University of California Irvine Medical Center, Orange; Jai Balkissoon, Pharmaceutical Product Development International, South San Francisco, CA; Lainie P. Martin, Fox Chase Cancer Center, Philadelphia, PA; Jeanne M. Schilder, Indiana University Medical Center, Indianapolis, IN; and Robert L. Coleman, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.8153DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962710PMC
July 2016

Moving beyond the platinum sensitive/resistant paradigm for patients with recurrent ovarian cancer.

Gynecol Oncol 2016 06 8;141(3):405-409. Epub 2016 Apr 8.

Cancer Treatment Centers of America, Philadelphia, PA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.03.005DOI Listing
June 2016

Ovarian Cancer: Current Treatment and Patient Management.

J Adv Pract Oncol 2016 Apr 1;7(3):271-273. Epub 2016 Apr 1.

University of Arizona Cancer Center, Phoenix, Arizona, and Cedars-Sinai Medical Center, Los Angeles, California.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679040PMC
April 2016

Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.

N Engl J Med 2016 Feb;374(8):738-48

From the California Pacific-Palo Alto Medical Foundation, Sutter Cancer Research Institute, San Francisco (J.K.C.); NRG Oncology-Gynecologic Oncology Group Statistics and Data Center, Roswell Park Cancer Institute, Buffalo, NY (M.F.B., H.H.); Massachusetts General Hospital, Boston (R.T.P., M.J.B.); University of Oklahoma, Oklahoma City (J.L.W.); Women and Infants Hospital, Providence, RI (P.A.D.S.); University of Pennsylvania (S.C.R.) and Fox Chase Cancer Center (L.P.M.) - both in Philadelphia; University of Colorado Cancer Center, Aurora (S.A.D.); University of Alabama at Birmingham, Birmingham (W.K.H.); James Cancer Center, Ohio State University, Columbus (D.M.O.); Minnesota Oncology/Hematology-Oncology Service, Edina (M.P.B.); Indiana University School of Medicine, Carmel (H.M.); and University of Arizona Cancer Center, Creighton University School of Medicine, and St. Joseph's Hospital and Medical Center (B.J.M.) - all in Phoenix.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081077PMC
http://dx.doi.org/10.1056/NEJMoa1505067DOI Listing
February 2016

Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life.

Clin Ther 2016 Mar 27;38(3):467-75. Epub 2016 Feb 27.

Program in Public Health, University of California Irvine, Irvine, California; Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California; Department of Medicine, General Internal Medicine, University of California Irvine, Irvine, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2016.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799758PMC
March 2016

Biosimilars: Extrapolating the evidence. A roundtable discussion.

EJC Suppl 2015 Dec 21;13(2):1-2. Epub 2016 Jan 21.

City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejcsup.2015.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724664PMC
December 2015

Reply to F.M. Muggia.

J Clin Oncol 2016 Mar 1;34(8):882-3. Epub 2016 Feb 1.

University of Arizona Cancer Center, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.4295DOI Listing
March 2016

Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.

Int J Gynecol Cancer 2016 Jan;26(1):199-207

*Department of Gynecologic Oncology, Sapporo West Kojinkai Clinic, Sapporo, Japan; †University of Arizona Cancer Center-Phoenix, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ; ‡Hôtel-Dieu, AP-HP, Université Paris Descartes, Paris, France; §Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah Health Care, Salt Lake City, UT; ∥Division of Radiation Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia; ¶Department of Surgery, Chonnam National University Medical School, Gwangju, South Korea; #Department of Oncology, University College Hospital London, London, United Kingdom; **Division of Gynecologic Oncology, Centre Hospitalier Universitaire de Québec, Quebec, Quebec, Canada; ††Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain; ‡‡Coordinating Center for Clinical Trials of the Phipps-University of Marburg, Marburg, Germany; §§GICOM Grupo Mexicano de Investigación en Cáncer de Ovario y Tumores Ginecológicos, A.C. México City, México; ∥∥Institute of Cancer Sciences, University of Manchester, St Mary's Hospital, Manchester, United Kingdom; ¶¶Biotechnology Research Division, National Fisheries Research and Development Institute, Busan, South Korea; ##Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ***Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD; †††Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; ‡‡‡Médecin - Spécialiste en Oncologie, Institut Curie, Paris, France; §§§Division of Radiation Oncology, Department Oncology, University of Calgary, Calgary, Alberta, Canada; ∥∥∥Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; ¶¶¶Chir

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000587DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831060PMC
January 2016

Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Int J Gynecol Cancer 2016 Jan;26(1):125-32

*Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine, Medical Center, Orange, CA; †Gynecologic Oncology Group, Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY; ‡Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, City of Hope Comprehensive Cancer Center, Duarte, CA; §The Research Institute at Nationwide Children's Hospital, Columbus, OH; ∥Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Arizona Cancer Center, Creighton University School of Medicine, St Joseph's Hospital and Medical Center, Phoenix, AZ; ¶Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Oklahoma, Oklahoma City, OK; #Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Cincinnati, OH; and **Department of Orthopedic Surgery, University of California, Irvine, Orange, CA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061499PMC
http://dx.doi.org/10.1097/IGC.0000000000000563DOI Listing
January 2016

Disparities in Vulvar Cancer Reported by the National Cancer Database: Influence of Sociodemographic Factors.

Obstet Gynecol 2015 Oct;126(4):792-802

Division of Gynecologic Oncology, University of Arizona Cancer Center, and the Department of Obstetrics and Gynecology, Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, and the University of Arizona College of Public Health, Tucson, Arizona; and the Surveillance and Health Services Research Program, American Cancer Society, and the Department of Health Policy and Management, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/greenjournal/2015/10000/Dispari
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/AOG.0000000000001033DOI Listing
October 2015

Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer.

Clin Cancer Res 2015 Sep 13;21(17):3829-35. Epub 2015 Jul 13.

The Division of Gynecologic Oncology, University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, Arizona.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0088DOI Listing
September 2015

State of the science: Emerging therapeutic strategies for targeting angiogenesis in ovarian cancer.

Gynecol Oncol 2015 Aug 9;138(2):223-6. Epub 2015 Jul 9.

Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.07.008DOI Listing
August 2015

Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.

Gynecol Oncol 2015 Sep 2;138(3):663-7. Epub 2015 Jul 2.

University of Arizona Cancer Center-Phoenix, Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, 350 West Thomas Road, Phoenix, AZ 85013, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.06.037DOI Listing
September 2015

The American Society of Clinical Oncology 51st Annual Meeting 2015: An overview and summary of selected abstracts.

Gynecol Oncol 2015 Aug 27;138(2):227-34. Epub 2015 Jun 27.

Division of Gynecologic Oncology, University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.06.028DOI Listing
August 2015

Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study.

J Clin Oncol 2015 May 23;33(13):1460-6. Epub 2015 Mar 23.

Devansu Tewari, Kaiser Permanente Irvine Medical Center, Irvine; John K. Chan, California Pacific/Palo Alto Medical Foundation/Sutter Research Institute, San Francisco, CA; James J. Java, Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY; Ritu Salani, Wexner Medical Center, Ohio State University, Columbus; Thomas Herzog, University of Cincinnati, Cincinnati, OH; Deborah K. Armstrong, Sidney Kimmel Comprehensive Cancer Center, John Hopkins University School of Medicine, Baltimore, MD; Maurie Markman, Eastern Regional Medical Center, Cancer Treatment Centers of America, Philadelphia, PA; Bradley J. Monk, Creighton University School of Medicine, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/obgynsurvey/2015/08000/Long_Ter
Web Search
https://www.cmich.edu/colleges/cmed/Documents/Research/Sagin
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.55.9898
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.55.9898DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404424PMC
May 2015

A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer.

Gynecol Oncol 2015 Jun 10;137(3):490-6. Epub 2015 Mar 10.

The Division of Gynecologic Oncology, University of California, Irvine Medical Center, Orange, CA 92868, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.02.027DOI Listing
June 2015

In assessing surrogate clinical trial end points: drug safety is a requisite.

J Clin Oncol 2015 May 2;33(13):1511-2. Epub 2015 Mar 2.

University of Alabama at Birmingham, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.8169DOI Listing
May 2015

Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trial.

J Clin Oncol 2015 Apr 23;33(10):1171-9. Epub 2015 Feb 23.

Lari Wenzel, Kathryn Osann, Susie Hsieh, Jo A. Tucker, and Edward L. Nelson, University of California Irvine, Irvine, CA; and Bradley J. Monk, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.4079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372853PMC
April 2015

Development of a platform for systemic antiangiogenesis therapy for advanced cervical cancer.

Clin Adv Hematol Oncol 2014 Nov;12(11):737-48

University of Arizona Cancer Center, Phoenix, AZ.

View Article

Download full-text PDF

Source
November 2014

Reply to W.A.A. Tjalma and J.S. Grossman.

J Clin Oncol 2015 Mar 9;33(8):966. Epub 2015 Feb 9.

Division of Gynecologic Oncology, University of California, Irvine Medical Center, Orange, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.6205DOI Listing
March 2015

Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.

Gynecol Oncol 2015 Apr 23;137(1):86-92. Epub 2015 Jan 23.

Division of Gynecologic Oncology, University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.01.537DOI Listing
April 2015

In vitro chemoresponse in metachronous pairs of ovarian cancers.

Anticancer Res 2014 Dec;34(12):7191-6

University of Arizona Cancer Center-Phoenix Creighton University School of Medicine at St. Joseph's, Department of Obstetrics and Gynecology, Phoenix, AZ, U.S.A.

View Article

Download full-text PDF

Source
December 2014

Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204.

Int J Gynecol Cancer 2015 Feb;25(2):303-8

*Creighton University School of Medicine at the University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center, Phoenix, AZ; †NRG Oncology/Gynecologic Oncology Group Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY; ‡University of California at Irvine, Irvine, CA; §MD Anderson Cancer Center, Houston, TX; ∥Northwestern University/Prentice Women's Hospital, Chicago, IL; and ¶Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000328DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506195PMC
February 2015

Incorporation of pazopanib in maintenance therapy of ovarian cancer.

J Clin Oncol 2014 Oct 15;32(30):3374-82. Epub 2014 Sep 15.

Andreas du Bois, Rainer Kimmig, Klaus H. Baumann, Christian Kurzeder, Ulrich Canzler, Philipp Harter, AGO Ovarian Cancer Study Group (AGO); Andreas du Bois, Christian Kurzeder, Philipp Harter, Kliniken Essen Mitte; Rainer Kimmig, West German Tumor Center, University of Duisburg-Essen, Essen; Joern Rau, Carmen Schade-Brittinger, Coordinating Center for Clinical Trials, Philipps-University of Marburg; Klaus H. Baumann, University of Marburg, Marburg; Ulrich Canzler, University Hospitals Carl Gustav Carus, Dresden, Germany; Anne Floquet, Isabelle Ray-Coquard, Marie-Ange Mouret-Reynier, Anne Lesoin, Eric Pujade-Lauraine, Groupe d'Investigateurs Nationaux pour l'Étude des Cancers Ovariens; Anne Floquet, Institut Bergonié, Bordeaux; Isabelle Ray-Coquard, Centre Léon Bérard, Lyon; Marie-Ange Mouret-Reynier, Centre Jean Perrin, Clermont-Ferrand; Anne Lesoin, Centre Oscar Lambret, Lille; Eric Pujade-Lauraine, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes, Paris, France; Jae-Weon Kim, Jae-Hoon Kim, Korean Gynecologic Oncology Group; Jae-Weon Kim, Seoul National University; Jae-Hoon Kim, Yonsei University; Byoung-Gie Kim, Samsung Medical Center, Seoul, Republic of Korea; Josep M. del Campo, Ivan Diaz-Padilla, Spanish Ovarian Cancer Research Group; Josep M. del Campo, Vall d'Hebron University Hospital, Barcelona; Ivan Diaz-Padilla, Centro Integral Oncologico Clara Campal, HM Hospitales, Madrid, Spain; Michael Friedlander, Paul Vasey, Australian and New Zealand Gynecological Oncology Group; Michael Friedlander, The Prince of Wales Clinical School University of New South Wales, Randwick, New South Wales; Paul Vasey, Wesley Medical Centre, Auchenflower, Queensland, Australia; Sandro Pignata, Giovanni Scambia, Multicenter Italian Trials in Ovarian Cancer; Sandro Pignata, Istituto Nazionale Tumori Fondazione G. Pascale, Naples; Nicoletta Colombo, Mario Negri Gynecologic Oncology Group and University of Milan-Bicocca and European Institute of Oncology, Milan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7348DOI Listing
October 2014

Factors associated with poor quality of life among cervical cancer survivors: implications for clinical care and clinical trials.

Gynecol Oncol 2014 Nov 3;135(2):266-72. Epub 2014 Sep 3.

Program in Public Health, University of California, Irvine, Irvine, CA, USA; Department of Medicine, Health Policy Research Institute, University of California, Irvine, Irvine, CA, USA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Irvine, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.08.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479396PMC
November 2014

SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm.

Gynecol Oncol 2014 Oct 12;135(1):3-7. Epub 2014 Aug 12.

The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698962PMC
October 2014